Cancer BiologybioRxiv
Robust and clinically relevant prediction of response to anti-cancer drugs via network integration of molecular profiles
M. Franco, A. Jeggari, S. Peuget…·A. Alexeyenko
The paper introduces NEAmarker, a method for pathway-level biomarker discovery that outperforms existing methods in cross-platform integration, consistency, and survival prediction.
DOI 10.1038/s41598-019-39019-2